🇺🇸 FDA
Patent

US 7776320

Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex

granted A61KA61K38/185A61P

Quick answer

US patent 7776320 (Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex) held by The Regents of the University of California expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/185, A61P, A61P25/00, A61P25/28